Drug and disease signature integration identifies synergistic combinations in glioblastoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Drug and disease signature integration identifies synergistic combinations in glioblastoma ; volume:9 ; number:1 ; day:14 ; month:12 ; year:2018 ; pages:1-13 ; date:12.2018
Nature Communications ; 9, Heft 1 (14.12.2018), 1-13, 12.2018
- Urheber
-
Stathias, Vasileios
Jermakowicz, Anna M.
Maloof, Marie E.
Forlin, Michele
Walters, Winston
Suter, Robert K.
Durante, Michael A.
Williams, Sion L.
Harbour, J. William
Volmar, Claude-Henry
Lyons, Nicholas J.
Wahlestedt, Claes
Graham, Regina M.
Ivan, Michael E.
Komotar, Ricardo J.
Sarkaria, Jann N.
Subramanian, Aravind
Golub, Todd R.
Schürer, Stephan C.
Ayad, Nagi G.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-018-07659-z
- URN
-
urn:nbn:de:101:1-2019012722324199599578
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stathias, Vasileios
- Jermakowicz, Anna M.
- Maloof, Marie E.
- Forlin, Michele
- Walters, Winston
- Suter, Robert K.
- Durante, Michael A.
- Williams, Sion L.
- Harbour, J. William
- Volmar, Claude-Henry
- Lyons, Nicholas J.
- Wahlestedt, Claes
- Graham, Regina M.
- Ivan, Michael E.
- Komotar, Ricardo J.
- Sarkaria, Jann N.
- Subramanian, Aravind
- Golub, Todd R.
- Schürer, Stephan C.
- Ayad, Nagi G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs
Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature
Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells
piscesCSM: prediction of anticancer synergistic drug combinations
CD95 identifies glioblastoma stem cells
A connectivity signature for glioblastoma [Abstract]
Synergistic Target Combinations Against Obesity: Focus on MCHR1/H3R Modulation
Prediction of synergistic drug combinations using PCA-initialized deep learning
Synergistic Anti-Dermatophytic Potential of Nanoparticles and Essential Oils Combinations
Predicting anticancer synergistic drug combinations based on multi-task learning
A review on graph neural networks for predicting synergistic drug combinations
Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs
Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature
Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells
piscesCSM: prediction of anticancer synergistic drug combinations
CD95 identifies glioblastoma stem cells
A connectivity signature for glioblastoma [Abstract]
Synergistic Target Combinations Against Obesity: Focus on MCHR1/H3R Modulation
Prediction of synergistic drug combinations using PCA-initialized deep learning
Synergistic Anti-Dermatophytic Potential of Nanoparticles and Essential Oils Combinations
Predicting anticancer synergistic drug combinations based on multi-task learning
A review on graph neural networks for predicting synergistic drug combinations
Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs
Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature
Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells
piscesCSM: prediction of anticancer synergistic drug combinations
CD95 identifies glioblastoma stem cells
A connectivity signature for glioblastoma [Abstract]
Synergistic Target Combinations Against Obesity: Focus on MCHR1/H3R Modulation
Prediction of synergistic drug combinations using PCA-initialized deep learning
Synergistic Anti-Dermatophytic Potential of Nanoparticles and Essential Oils Combinations
Predicting anticancer synergistic drug combinations based on multi-task learning